In addition, patients were required to have a minimum of 1 relapse within the year prior to study enrollment and 5 or fewer gadolinium-enhancing brain lesions.

• 此外，病人在进入研究试验前一年最好有一次复发和等于（或少于）5个的钆增强脑部病变。